181 related articles for article (PubMed ID: 14766818)
1. Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France.
Colson P; Henry M; Tourres C; Lozachmeur D; Gallais H; Gastaut JA; Moreau J; Tamalet C
J Clin Microbiol; 2004 Feb; 42(2):570-7. PubMed ID: 14766818
[TBL] [Abstract][Full Text] [Related]
2. HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1.
Pieniazek D; Rayfield M; Hu DJ; Nkengasong JN; Soriano V; Heneine W; Zeh C; Agwale SM; Wambebe C; Odama L; Wiktor SZ
AIDS; 2004 Feb; 18(3):495-502. PubMed ID: 15090802
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France.
Colson P; Henry M; Tivoli N; Gallais H; Gastaut JA; Moreau J; Tamalet C
J Med Virol; 2005 Mar; 75(3):381-90. PubMed ID: 15648062
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors.
Damond F; Brun-Vezinet F; Matheron S; Peytavin G; Campa P; Pueyo S; Mammano F; Lastere S; Farfara I; Simon F; Chene G; Descamps D
J Clin Microbiol; 2005 Jan; 43(1):484-7. PubMed ID: 15635022
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of drug resistance-related polymorphisms in treatment-naive individuals infected with nonsubtype B HIV type 1 in Cameroon.
Youngpairoj AS; Alemnji GA; Eno LT; Lyonga EJ; Eloundou MA; Shanmugam V; Mpoudi EN; Folks TM; Kalish ML; Pieniazek D; Fonjungo PN
AIDS Res Hum Retroviruses; 2012 Jul; 28(7):675-84. PubMed ID: 21923557
[TBL] [Abstract][Full Text] [Related]
6. Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors.
Ntemgwa M; Brenner BG; Oliveira M; Moisi D; Wainberg MA
Antimicrob Agents Chemother; 2007 Feb; 51(2):604-10. PubMed ID: 17116674
[TBL] [Abstract][Full Text] [Related]
7. Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy.
Rodés B; Holguín A; Soriano V; Dourana M; Mansinho K; Antunes F; González-Lahoz J
J Clin Microbiol; 2000 Apr; 38(4):1370-4. PubMed ID: 10747109
[TBL] [Abstract][Full Text] [Related]
8. Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing.
O'Meara D; Wilbe K; Leitner T; Hejdeman B; Albert J; Lundeberg J
J Clin Microbiol; 2001 Feb; 39(2):464-73. PubMed ID: 11158091
[TBL] [Abstract][Full Text] [Related]
9. Identification and distribution of HIV type 1 genetic diversity and protease inhibitor resistance-associated mutations in Shanghai, P. R. China.
Zhong P; Kang L; Pan Q; Konings F; Burda S; Ma L; Xue Y; Zheng X; Jin Z; Nyambi P
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):91-101. PubMed ID: 14501800
[TBL] [Abstract][Full Text] [Related]
10. Genetic diversity of human immunodeficiency virus-1 isolates in Paraná, Brazil.
Toledo PV; Carvalho DS; Rossi SG; Brindeiro R; de Queiroz-Telles F
Braz J Infect Dis; 2010; 14(3):230-6. PubMed ID: 20835505
[TBL] [Abstract][Full Text] [Related]
11. Naturally occurring sequence polymorphisms within HIV type 1 group O protease.
Luk KC; Kaptué L; Zekeng L; Soriano V; Gürtler L; Devare SG; Schochetman G; Hackett J
AIDS Res Hum Retroviruses; 2001 Nov; 17(16):1555-61. PubMed ID: 11709100
[TBL] [Abstract][Full Text] [Related]
12. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
[TBL] [Abstract][Full Text] [Related]
13. Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors.
Cabana M; Clotet B; Martínez MA
J Med Virol; 1999 Dec; 59(4):480-90. PubMed ID: 10534730
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features.
Fonjungo PN; Mpoudi EN; Torimiro JN; Alemnji GA; Eno LT; Lyonga EJ; Nkengasong JN; Lal RB; Rayfield M; Kalish ML; Folks TM; Pieniazek D
J Clin Microbiol; 2002 Mar; 40(3):837-45. PubMed ID: 11880402
[TBL] [Abstract][Full Text] [Related]
15. [Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor].
Mouroux M; Bossi P; Yvon-Groussin A; Delaugerre C; Valantin MA; Tubiana R; Coutellier A; Bonmarchand M; Bricaire F; Katlama C; Agut H; Huraux JM; Calvez V
Pathol Biol (Paris); 1999 May; 47(5):549-52. PubMed ID: 10418038
[TBL] [Abstract][Full Text] [Related]
16. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.
de Baar MP; Janssens W; de Ronde A; Fransen K; Colebunders R; Kestens L; van der Groen G; Goudsmit J
AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1385-94. PubMed ID: 11018858
[TBL] [Abstract][Full Text] [Related]
17. Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences.
Yahi N; Tamalet C; Tourrès C; Tivoli N; Ariasi F; Volot F; Gastaut JA; Gallais H; Moreau J; Fantini J
J Clin Microbiol; 1999 Dec; 37(12):4099-106. PubMed ID: 10565938
[TBL] [Abstract][Full Text] [Related]
18. Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.
Vergne L; Stuyver L; Van Houtte M; Butel C; Delaporte E; Peeters M
J Clin Virol; 2006 May; 36(1):43-9. PubMed ID: 16563858
[TBL] [Abstract][Full Text] [Related]
19. Sequence analysis of the HIV-1 protease coding region of 18 HIV-1-infected patients prior to HAART and possible implications on HAART.
Gehringer H; Bogner JR; Goebel FD; Nitschko H; von der Helm K
J Clin Virol; 2000 Aug; 17(2):137-41. PubMed ID: 10942094
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor.
Bossi P; Mouroux M; Yvon A; Bricaire F; Agut H; Huraux JM; Katlama C; Calvez V
J Clin Microbiol; 1999 Sep; 37(9):2910-2. PubMed ID: 10449474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
